Company overview

Get to know Exosens

Exosens is a high-tech company, with more than 85 years of experience in the innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. Today, it offers its customers detection components and solutions such as advanced cameras, neutron and gamma detectors, instrument detectors and light intensifier tubes. This allows Exosens to respond to complex issues in extremely demanding environments by offering tailor-made solutions to its customers. Thanks to its sustained investments, Exosens is internationally recognized as a major innovator in optoelectronics, with production and R&D carried out on 12 sites, in Europe and North America, and with over 2,000 employees. Exosens is listed on compartment A of Euronext Paris regulated market (Ticker: EXENS; ISIN: FR001400Q9V2). Exosens is a member of Euronext Tech Leaders segment and is also included in several indices, including SBF 120, CAC All-Tradable, CAC Mid 60, FTSE Total Cap and MSCI France Small Cap. 

More about Exosens

Exosens’ growth strategy is based on the five pillars

The Group’s ambition is to strengthen its position as a leading technology platform addressing the entire spectrum of particles and light, enabling it to pursue profitable growth by positioning itself in high- growth markets based on a need for high value-added technologies. By drawing on its strong capacity for innovation, its global commercial presence and targeted acquisitions, Exosens aims to generate a high level of profitability and cash flow. Exosens is focusing its strategy on five pillars, which benefit from significant synergies between them:

INNOVATE IN TECHNOLOGY INNOVATE IN TECHNOLOGY

Exosens intends to draw on its strong innovation capacities to develop new technologies (such as scintillators, photocathodes and artificial intelligence), improve the size, weight and energy consumption (SWAP) of its products, enhance their performance (especially sensitivity and speed), and improve product testing capacities and ergonomics. This innovation is deployed in the Group’s 4 end markets: defence, life sciences, industrial control and nuclear power.

Exosens has made a name for itself worldwide by launching a number of products featuring innovative technology, such as the 16mm image intensifier tube, which has enabled the design of night vision binoculars that are now a market benchmark, and the high-dynamic BPTOF detector for microbiology and pharmaceutical mass spectrometry.

Exosens can rely on its long-term relationships with an ecosystem of players at the cutting edge of technological innovation (university research centres, technology companies, scientific laboratories, etc.) covering all its end markets.  

FOCUS ON TARGETED NICHES FOCUS ON TARGETED NICHES

Exosens aims to be a leader in high-growth niche markets where performance standards are extremely high and critical:

  • semiconductor inspection 
  • methane detection 
  • neutron monitoring in nuclear reactors, 
  • predictive maintenance for high-voltage power lines, etc.
     

Exosens is also seeking to make its positioning difficult to replicate. To achieve this, Exosens can rely on :

  • its technological and strategic advantage, 
  • its very long-term relationships with customers and end-users, 
  • the design of products for critical applications with high standards of quality and reliability, 
  • unique industrial know-how and in-house skills,
  • operational excellence in industrial processes.

By offering products that meet the demand of high-growth niche markets, Exosens has been able to significantly increase its market share. 

GROW WITH CUSTOMERS GROW WITH CUSTOMERS

The Group intends to build on its long-term relationships with its major customers to increase and secure the repeatability of its revenue, and thus grow faster than its underlying markets.

The products sold by Exosens are generally designed in direct collaboration with the manufacturer or the end-user themselves in order to meet their specific needs throughout the life of the system, which then allows a short sales cycle once the product has been qualified by the end-user. 

CSR EMBEDDED AT CORE CSR EMBEDDED AT CORE

The Group’s strategy is geared towards pursuing business and production that contribute to the sustainable development of the economy.

Exosens products are used in a wide range of applications to help combat climate change. For example, the Group is developing products to detect methane gas in a market that is growing rapidly as a result of the development of regulations in this area. In the field of methane detection, the Group has developed hyper-spectral cameras that can identify and detect methane emissions in real time, whether by day or night, on snow or in water. 

ACCELERATE WITH SELECTIVE EXTERNAL GROWTH ACCELERATE WITH SELECTIVE EXTERNAL GROWTH

The Group’s growth strategy is based in particular on a dynamic acquisitions policy, which is intended to enable it to generate additional revenue growth through carefully targeted acquisitions of companies selected according to strict criteria and implemented in line with the characteristics of the markets in which the Group operates.

In particular, the Group targets acquisitions that can provide it with high value-added technologies and compatible with its technology platform that complement its current product portfolio, enable it to expand the addressable market and/or enable it to achieve or strengthen a leadership position, while giving the acquired targets the leverage provided by its global commercial footprint and its expertise in operational excellence, in order to accelerate the growth of the Group’s activities, improve its profitability and strengthen its cash generation.

Exosens’ external growth strategy is focused primarily on the Detection and Imaging market, with the aim of achieving a balanced split between its Amplification and Detection and Imaging activities by 2027.

Key Figures in 2025

4

Growing niche markets

300+

Proven technology R&D patents

7,6%

of revenue invested in gross R&D

12

R&D and production sites

2000+

Employees worldwide

300+

Customers

20+

Years of commercial relationships with top 10 customers

70+

Countries, 93% overseas revenus

468.2M €

Revenue in 2025

32,4%

Adjusted EBITDA margin

73,6%

Cash conversion in 2025

9

International acquisitions since 2022

Board of directors

PhotoBoard-Jean-Hubert-Vial

Jean-Hubert Vial

Chairman of the Board of Directors

Jérôme Cerisier

Jérôme Cerisier

Chief Executive Officer and director

PhotoBoard-Christophe-Bernardini

Christophe Bernardini

Director

Michel Mariton

Michel Mariton

Independent Director

Photo Board of Director Wendy Kool Foulon

Wendy Kool-Foulon

Independent Director

PhotoBoard-Brigitte

Brigitte Geny

Independent Director

Dorianne Bonfils

Bpifrance Investissement

Independent Director - Represented by Dorianne Bonfils

PhotoBoard-Salim-Helou

HLD Europe

Director - Represented by Salim Helou

François Calvarin

François Calvarin

Censor

Executive team

Jérôme Cerisier

Jérôme Cerisier

Chief Executive Officer

Quynh-Boi Demey

Quynh-Boi Demey

Chief Financial Officer

Claire Valentin

Claire Valentin

Executive General Manager - Instruments Business Unit

Pascal Joseph

Pascal Joseph

Chief Operations Officer

Christel-Loic Tisse

Christel-Loic Tisse

Chief Technology Officer

PhotoBoard-Bella

Bella Zisere

Chief People and Culture Officer

Frederic Guilhem

Frederic Guilhem

Executive General Manager - Night Vision Business Unit

Ulrich Laupper

Ulrich Laupper

Executive General Manager - Ultimate Detection

Paul Ryckaert

Paul Ryckaert

Chief Strategy Officer

Guillaume Bunoz

Guillaume Bunoz

Executive General Manager - Advanced Imaging

POST_LK_GENERALE POST_LK_INDIVIDUALS_0 Exosens - CSR Exosens - CSR

Our CSR policy

We aim above all to have a positive impact on our stakeholders, society and the environment, and therefore engage on a more sustainable business.

Find out more about our commitments to a a safe, fair and sustainable future.

Discover